Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TruB pseudouridine synthase family member 2 (TRUB2) is a mitochondrial enzyme that catalyzes the isomerization of uridine to pseudouridine in mitochondrial mRNAs, such as COXI and COXIII, and in a subset of tRNAs—especially synthesizing pseudouridine(55) from uracil-55 in the psi GC loop of tRNAs. As part of a protein-RNA module with other mitochondrial proteins and 16S mt-rRNA, TRUB2 plays a regulatory role in 16S mt-rRNA abundance and is essential for mitochondrial translation. Genetic defects in TRUB2 have been linked to autosomal recessive spastic ataxia and primary coenzyme Q10 deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TruB pseudouridine synthase family member 2 (TRUB2).